Keros Therapeutics, Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$2
Book Value Per Share
$8
Free Cash Flow Per Share
$3
Cash Per Share
$8
Revenue Per Share
$6
OCF Per Share
$3
Return on Equity
19.9%
Return on Assets
18.2%
Return on Invested Capital
14.6%
Current Ratio
15.45
Quick Ratio
15.45
Asset Turnover
0.51
Days Sales Outstanding
5.34
R&D / Revenue
53.2%
SBC / Revenue
11.8%
Capex / Revenue
0.6%
Working Capital
$295M
Net Current Asset Value
$281M
Invested Capital
$303M
OCF / Net Income
1.24
FCF / Net Income
1.22
Accruals Ratio (Sloan)
-6.1%
Net Debt
$-287M
Net Debt / EBITDA
-4.16
Interest Coverage
—
Cash Coverage
—
Capex Coverage
69.31
Tangible Common Equity
$303M
TCE / Total Assets
89.7%
NOPAT
$64M
Cash ROIC
24.2%
WC / Revenue
121.0%
Capex / D&A
1.03
Reinvestment Rate
0.1%
Total Payout Ratio
431.0%
Asset Growth vs Revenue Growth
166.4%
Book Value 5Y CAGR
3.0%
Stock Price (FY-end)
$20
Market Cap
$771M
P/E Ratio
8.86
P/S Ratio
3.16
P/B Ratio
2.54
P/TB Ratio
2.54
P/OCF Ratio
7.17
P/FCF Ratio
7.27
Enterprise Value
$483M
EV / EBITDA
7.00
EV / Sales
1.98
EV / FCF
4.56
FCF Yield
13.7%
Shareholder Yield
44.9%
Buyback Yield
48.7%
R&D Yield
16.8%
Capex Yield
0.2%
Graham Number
$20
Shares Variation (YoY)
1.1%
Beta (5Y)
1.13
Cost of Equity
10.1%
52W High
$22
52W Low
$10
Trailing Return 1Y
24.0%
Trailing Return 5Y
-73.8%
F-Score (Piotroski)
5.00
Z-Score (Altman)
13.69
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.